Vladimir S Gordeev

1. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
   2017/11/22 by Ranjit Manchanda, Shreeya Patel, Vladimir Sergeevich Gordeev +19 · 25 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · Economics, Econometrics and Finance · #BRCA gene mutations in cancer #PARP inhibition in cancer therapy #Health Systems, Economic Evaluations, Quality of Life